The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
33
No.
1
January 29, 2010Jan 29, 2010
Free
DOWNLOAD THE PDF

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

Avastin Improves PFS Compared To Chemo Alone

Two Second-Line CML Drugs Work Front-Line, Studies Find

NCI Cooperative Group Clinical Trials Approved

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account